We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


ActiveSight Signs Protein Crystallography Agreement with Novo Nordisk

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "ActiveSight Signs Protein Crystallography Agreement with Novo Nordisk"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

ActiveSight has announced that it has signed an agreement with Novo Nordisk A/S to provide protein crystallography services.

ActiveSight will co-crystallize Novo Nordisk proprietary molecules with proteins expressed by ActiveSight.

"We are very pleased to add a company of Novo Nordisk's stature to our growing customer base," stated Ronald V. Swanson, Ph.D., Chief Scientific Officer for ActiveSight.

"We look forward to supplying their scientists with structural information to accelerate their discovery efforts."

This is the first announced agreement of 2006 for the protein crystallography services provider, which was founded in 2003.